← Back to Search

Behavioural Intervention

Stronger at Home Intervention for Hip Fracture (S@H Trial)

N/A
Recruiting
Research Sponsored by Queen's University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 7 days of discharge, as well as within 3.5 months, 6 months, 9 months, and 12 months.
Awards & highlights

S@H Trial Summary

This trial will test if the Stronger at Home program can help older adults recover better after a hip fracture than usual care.

Who is the study for?
This trial is for older adults, aged 65 or above, who have had a hip fracture from a fall and live at home or in a retirement home within 25km of the recruitment site. It's not for those coming from/going to long-term care, with non-hip fractures, unable to consent without help, having fractures due to diseases like cancer, non-English speakers without translators, injured in hospital, terminally ill or advised against exercise.Check my eligibility
What is being tested?
The trial tests 'Stronger at Home,' an individualized 14-week home rehab program versus usual care post-hip fracture. The study measures how well participants recover functionally by the end of the program and checks its cost-effectiveness and long-term benefits up to one year after discharge.See study design
What are the potential side effects?
Since this intervention involves education and exercise programs tailored for elderly patients recovering from hip fractures rather than medication or surgery, side effects are minimal but may include typical risks associated with physical activity such as muscle soreness or strain.

S@H Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 7 days of discharge, as well as within 3.5 months, 6 months, 9 months, and 12 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 7 days of discharge, as well as within 3.5 months, 6 months, 9 months, and 12 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The Lower Extremity Functional Scale (LEFS)
Secondary outcome measures
2-Minute Walk Test (2MWT)
Clinical Frailty Scale
Modified Falls Efficacy Scale
+5 more
Other outcome measures
Charlson Comorbidity Index
Health Resource Utilization Questionnaire (adapted version)
Health Resource Utilization diary
+3 more

S@H Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention (Stronger at Home model)Experimental Treatment1 Intervention
This study implements a 14-week home-based rehabilitation program for older adults after hip fractures. Participants will receive 8 home visits by a Physiotherapist (PT) and/or Physio assistant(PTA), focusing on individualized exercise programs and pain self-management. The intervention aims to improve functional recovery and includes PT-led assessments, exercise adjustments, and discharge assessments. PTAs support exercise delivery and education. The clinical team comprises PTs and PTAs, receiving training on exercise principles, pain education, and goal setting. The program emphasizes progressive strengthening, balance, and functional exercises, adhering to evidence-based principles. The intervention aims to enhance efficiency, reduce wait times, and promote adherence.
Group II: Control (usual care)Active Control1 Intervention
The control group will receive usual home care provided by the healthcare system, which could vary between cases. We'll document their received care during follow-ups as it is inconsistent and poorly recorded. Regular check-in calls by the study coordinator will remind them of assessments, reducing attrition.

Find a Location

Who is running the clinical trial?

Queen's UniversityLead Sponsor
366 Previous Clinical Trials
121,537 Total Patients Enrolled
Dr. Mohammad Auais, PhDLead Sponsor
2 Previous Clinical Trials
69 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is access to this scientific inquiry available for participants currently?

"The clinicaltrials.gov database confirms that this trial, which first appeared on 17th October 2023 is actively enlisting candidates for participation. Its listing was recently updated on the same date as well."

Answered by AI

To what extent is eligibility for this trial being extended?

"Affirmative. As per the details hosted on clinicaltrials.gov, this medical study began recruiting participants when it was launched in October 17th 2023 and is still actively seeking volunteers. 200 patients are required from a single site to complete the trial."

Answered by AI
~133 spots leftby Oct 2027